-
1
-
-
64949131873
-
Tentacles of venom: Toxic protein convergence in the Kingdom Animalia
-
Fry, B.G.; Roelants, K.; Norman, J.A. Tentacles of venom: Toxic protein convergence in the Kingdom Animalia. J. Mol. Evol. 2009, 68, 311-321
-
(2009)
J. Mol. Evol
, vol.68
, pp. 311-321
-
-
Fry, B.G.1
Roelants, K.2
Norman, J.A.3
-
3
-
-
84925840665
-
Ueber das zustandekommen der diphterie-immunitaet und der tetanus-immunitatet bei thieren
-
Behring, E.; Kitasato, S. Ueber das zustandekommen der diphterie-immunitaet und der tetanus-immunitatet bei thieren. Deutsch. Med. Wochenschr. 1890, 16, 1113-1114
-
(1890)
Deutsch. Med. Wochenschr
, vol.16
, pp. 1113-1114
-
-
Behring, E.1
Kitasato, S.2
-
4
-
-
78149234586
-
Passive immunotherapy today: Brief history
-
Goyffon, M. Passive immunotherapy today: Brief history. Biol. Aujourdhui 2010, 204, 51-54
-
(2010)
Biol. Aujourdhui
, vol.204
, pp. 51-54
-
-
Goyffon, M.1
-
5
-
-
53649102120
-
History of immunoglobulin replacement
-
Eibl, M.M. History of immunoglobulin replacement. Immunol. Allergy Clin. N. Am. 2008, 28, 737-764
-
(2008)
Immunol. Allergy Clin. N. Am
, vol.28
, pp. 737-764
-
-
Eibl, M.M.1
-
7
-
-
0028876405
-
Intravenous immunoglobins (IVIGs) to prevent and treat infectious diseases
-
Cross, A.S. Intravenous immunoglobins (IVIGs) to prevent and treat infectious diseases. Adv. Exp. Med. Biol. 1995, 383, 123-130
-
(1995)
Adv. Exp. Med. Biol
, vol.383
, pp. 123-130
-
-
Cross, A.S.1
-
8
-
-
64349107630
-
Development trends for therapeutic antibody fragments
-
Nelson, A.L.; Reichert, J.M. Development trends for therapeutic antibody fragments. Nat. Biotechnol. 2009, 27, 331-337
-
(2009)
Nat. Biotechnol
, vol.27
, pp. 331-337
-
-
Nelson, A.L.1
Reichert, J.M.2
-
9
-
-
84863480395
-
Molecular engineering of antibodies for therapeutic and diagnostic purposes
-
Ducancel, F.; Muller, B.H. Molecular engineering of antibodies for therapeutic and diagnostic purposes. mAbs 2012, 4, 445-457
-
(2012)
MAbs
, vol.4
, pp. 445-457
-
-
Ducancel, F.1
Muller, B.H.2
-
10
-
-
84892590856
-
Antibodies to watch in 2014
-
Reichert, J.M. Antibodies to watch in 2014. mAbs 2014, 6, 5-14
-
(2014)
MAbs
, vol.6
, pp. 5-14
-
-
Reichert, J.M.1
-
11
-
-
84877955125
-
What are biosimilars and are they important?
-
Anonymous
-
Anonymous. What are biosimilars and are they important? Drug Ther. Bull. 2013, 51, 57-60
-
(2013)
Drug Ther. Bull
, vol.51
, pp. 57-60
-
-
-
12
-
-
0022417415
-
First clinical use of penicillin
-
Lawrie, R. First clinical use of penicillin. Br. Med. J. Clin. Res. Ed. 1985, 290, 397
-
(1985)
Br. Med. J. Clin. Res. Ed
, vol.290
, pp. 397
-
-
Lawrie, R.1
-
13
-
-
4444342539
-
Passive antibody therapy for infectious diseases
-
Casadevall, A.; Dadachova, E.; Pirofski, L. Passive antibody therapy for infectious diseases. Nat. Rev. Microbiol. 2004, 2, 695-703
-
(2004)
Nat. Rev. Microbiol
, vol.2
, pp. 695-703
-
-
Casadevall, A.1
Dadachova, E.2
Pirofski, L.3
-
14
-
-
33846891053
-
Bringing antivenoms to Sub-Saharan Africa
-
Stock, R.P.; Massougbodji, A.; Alagón, A.; Chippaux, J.-P. Bringing antivenoms to Sub-Saharan Africa. Nat. Biotechnol. 2007, 25, 173-177
-
(2007)
Nat. Biotechnol
, vol.25
, pp. 173-177
-
-
Stock, R.P.1
Massougbodji, A.2
Alagón, A.3
Chippaux, J.-P.4
-
15
-
-
84867903466
-
Emerging options for the management of scorpion stings
-
Chippaux, J.-P. Emerging options for the management of scorpion stings. Drug Des. Dev. Ther. 2012, 6, 165-173
-
(2012)
Drug Des. Dev. Ther
, vol.6
, pp. 165-173
-
-
Chippaux, J.-P.1
-
16
-
-
47649126821
-
Epidemiology of scorpionism: A global appraisa
-
Chippaux, J.-P.; Goyffon, M. Epidemiology of scorpionism: A global appraisa. Acta Trop. 2008, 107, 71-79
-
(2008)
Acta Trop
, vol.107
, pp. 71-79
-
-
Chippaux, J.-P.1
Goyffon, M.2
-
17
-
-
9644272420
-
Loxoscelism: Old obstacles, new directions
-
Hogan, C.J.; Barbaro, K.C.; Winkel, K. Loxoscelism: Old obstacles, new directions. Ann. Emerg. Med. 2004, 44, 608-624
-
(2004)
Ann. Emerg. Med
, vol.44
, pp. 608-624
-
-
Hogan, C.J.1
Barbaro, K.C.2
Winkel, K.3
-
19
-
-
84889093473
-
Safety of intravenous equine F(ab')2: Insights following clinical trials involving 1534 recipients of scorpion antivenom
-
Boyer, L.; Degan, J.; Ruha, A.-M.; Mallie, J.; Mangin, E.; Alagón, A. Safety of intravenous equine F(ab')2: Insights following clinical trials involving 1534 recipients of scorpion antivenom. Toxicon Off. J. Int. Soc. Toxinol. 2013, 76, 386-393
-
(2013)
Toxicon Off. J. Int. Soc. Toxinol
, vol.76
, pp. 386-393
-
-
Boyer, L.1
Degan, J.2
Ruha, A.-M.3
Mallie, J.4
Mangin, E.5
Alagón, A.6
-
20
-
-
78149273779
-
Guidelines for the production, control and regulation of snake antivenom immunoglobulins
-
Chippaux, J.-P. Guidelines for the production, control and regulation of snake antivenom immunoglobulins. Biol. Aujourdhui 2010, 204, 87-91
-
(2010)
Biol. Aujourdhui
, vol.204
, pp. 87-91
-
-
Chippaux, J.-P.1
-
21
-
-
0025918553
-
Isolation of IgGT from hyperimmune horse anti-snake venom serum: Its protective ability
-
Fernandes, I.; Takehara, H.A.; Mota, I. Isolation of IgGT from hyperimmune horse anti-snake venom serum: Its protective ability. Toxicon Off. J. Int. Soc. Toxinol. 1991, 29, 1373-1379
-
(1991)
Toxicon Off. J. Int. Soc. Toxinol
, vol.29
, pp. 1373-1379
-
-
Fernandes, I.1
Takehara, H.A.2
Mota, I.3
-
22
-
-
0037401660
-
Report of a WHO workshop on the standardization and control of antivenoms
-
Theakston, R.D.G.; Warrell, D.A.; Griffiths, E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon Off. J. Int. Soc. Toxinol. 2003, 41, 541-557
-
(2003)
Toxicon Off. J. Int. Soc. Toxinol
, vol.41
, pp. 541-557
-
-
Theakston, R.D.G.1
Warrell, D.A.2
Griffiths, E.3
-
23
-
-
79957509785
-
Antivenoms for the treatment of snakebite envenomings: The road ahead
-
Gutiérrez, J.M.; León, G.; Burnouf, T. Antivenoms for the treatment of snakebite envenomings: The road ahead. Biol. J. Int. Assoc. Biol. Stand. 2011, 39, 129-142
-
(2011)
Biol. J. Int. Assoc. Biol. Stand
, vol.39
, pp. 129-142
-
-
Gutiérrez, J.M.1
León, G.2
Burnouf, T.3
-
24
-
-
0031803535
-
Venoms, antivenoms and immunotherapy
-
Chippaux, J.P.; Goyffon, M. Venoms, antivenoms and immunotherapy. Toxicon Off. J. Int. Soc. Toxinol. 1998, 36, 823-846
-
(1998)
Toxicon Off. J. Int. Soc. Toxinol
, vol.36
, pp. 823-846
-
-
Chippaux, J.P.1
Goyffon, M.2
-
25
-
-
78149274387
-
Production of highly purified therapeutic immunoglobulins (HPTI): Analysis of a purification process
-
Nguyen, L. Production of highly purified therapeutic immunoglobulins (HPTI): Analysis of a purification process. Biol. Aujourdhui 2010, 204, 55-59
-
(2010)
Biol. Aujourdhui
, vol.204
, pp. 55-59
-
-
Nguyen, L.1
-
26
-
-
0035133283
-
Efficacy, safety, and use of snake antivenoms in the United States
-
Dart, R.C.; McNally, J. Efficacy, safety, and use of snake antivenoms in the United States. Ann. Emerg. Med. 2001, 37, 181-188
-
(2001)
Ann. Emerg. Med
, vol.37
, pp. 181-188
-
-
Dart, R.C.1
McNally, J.2
-
28
-
-
21344448811
-
Intravenous immunoglobulin therapy
-
Mouthon, L. Intravenous immunoglobulin therapy. Rev. Prat. 2005, 55, 1049-1056
-
(2005)
Rev. Prat
, vol.55
, pp. 1049-1056
-
-
Mouthon, L.1
-
29
-
-
38449084690
-
Historical development of monoclonal antibody therapeutics
-
Nissim, A.; Chernajovsky, Y. Historical development of monoclonal antibody therapeutics. Handb. Exp. Pharmacol. 2008, 181, 3-18
-
(2008)
Handb. Exp. Pharmacol
, vol.181
, pp. 3-18
-
-
Nissim, A.1
Chernajovsky, Y.2
-
30
-
-
0023864065
-
Monoclonal antibodies as magic bullets
-
Brodsky, F.M. Monoclonal antibodies as magic bullets. Pharm. Res. 1988, 5, 1-9
-
(1988)
Pharm. Res
, vol.5
, pp. 1-9
-
-
Brodsky, F.M.1
-
31
-
-
0019884081
-
A million dollars for the magic bullet
-
Sun, M. A million dollars for the magic bullet. Science 1981, 214, 1326-1327
-
(1981)
Science
, vol.214
, pp. 1326-1327
-
-
Sun, M.1
-
32
-
-
0036277088
-
A personal history of the CAMPATH-1H antibody
-
Waldmann, H. A personal history of the CAMPATH-1H antibody. Med. Oncol. Northwood Lond. Engl. 2002, 19 (Suppl.), S3-S9
-
(2002)
Med. Oncol. Northwood Lond. Engl
, vol.19
, Issue.SUPPL.
-
-
Waldmann, H.1
-
33
-
-
0023957561
-
Reversal of snake neurotoxin binding to mammalian acetylcholine receptor by specific antiserum
-
Gatineau, E.; Lee, C.Y.; Fromageot, P.; Menez, A. Reversal of snake neurotoxin binding to mammalian acetylcholine receptor by specific antiserum. Eur. J. Biochem. FEBS 1988, 171, 535-539
-
(1988)
Eur. J. Biochem. FEBS
, vol.171
, pp. 535-539
-
-
Gatineau, E.1
Lee, C.Y.2
Fromageot, P.3
Menez, A.4
-
34
-
-
0024044244
-
Monoclonal antibodies to scorpion toxins. Characterization and molecular mechanisms of neutralization
-
Bahraoui, E.; Pichon, J.; Muller, J.M.; Darbon, H.; Elayeb, M.; Granier, C.; Marvaldi, J.; Rochat, H. Monoclonal antibodies to scorpion toxins. Characterization and molecular mechanisms of neutralization. J. Immunol. 1988, 141, 214-220
-
(1988)
J. Immunol
, vol.141
, pp. 214-220
-
-
Bahraoui, E.1
Pichon, J.2
Muller, J.M.3
Darbon, H.4
Elayeb, M.5
Granier, C.6
Marvaldi, J.7
Rochat, H.8
-
35
-
-
0036027994
-
Induction of neutralizing antibodies against Tityus serrulatus scorpion toxins by immunization with a mixture of defined synthetic epitopes
-
Alvarenga, L.M.; Diniz, C.R.; Granier, C.; Chávez-Olórtegui, C. Induction of neutralizing antibodies against Tityus serrulatus scorpion toxins by immunization with a mixture of defined synthetic epitopes. Toxicon Off. J. Int. Soc. Toxinol. 2002, 40, 89-95
-
(2002)
Toxicon Off. J. Int. Soc. Toxinol
, vol.40
, pp. 89-95
-
-
Alvarenga, L.M.1
Diniz, C.R.2
Granier, C.3
Chávez-Olórtegui, C.4
-
36
-
-
30944449218
-
Monoclonal and recombinant antibodies, 30 years after
-
Laffly, E.; Sodoyer, R. Monoclonal and recombinant antibodies, 30 years after .... Hum. Antibodies 2005, 14, 33-55
-
(2005)
Hum. Antibodies
, vol.14
, pp. 33-55
-
-
Laffly, E.1
Sodoyer, R.2
-
37
-
-
27144532832
-
Human antibodies from transgenic animals
-
Lonberg, N. Human antibodies from transgenic animals. Nat. Biotechnol. 2005, 23, 1117-1125
-
(2005)
Nat. Biotechnol
, vol.23
, pp. 1117-1125
-
-
Lonberg, N.1
-
39
-
-
27144431943
-
Selecting and screening recombinant antibody libraries
-
Hoogenboom, H.R. Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 2005, 23, 1105-1116
-
(2005)
Nat. Biotechnol
, vol.23
, pp. 1105-1116
-
-
Hoogenboom, H.R.1
-
40
-
-
38849132141
-
Subtractive single-chain antibody (scFv) phage-display: Tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules
-
Eisenhardt, S.U.; Schwarz, M.; Bassler, N.; Peter, K. Subtractive single-chain antibody (scFv) phage-display: Tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules. Nat. Protoc. 2007, 2, 3063-3073
-
(2007)
Nat. Protoc
, vol.2
, pp. 3063-3073
-
-
Eisenhardt, S.U.1
Schwarz, M.2
Bassler, N.3
Peter, K.4
-
41
-
-
60549116209
-
A compact phage display human scFv library for selection of antibodies to a wide variety of antigens
-
Pansri, P.; Jaruseranee, N.; Rangnoi, K.; Kristensen, P.; Yamabhai, M. A compact phage display human scFv library for selection of antibodies to a wide variety of antigens. BMC Biotechnol. 2009, 9, 6
-
(2009)
BMC Biotechnol
, vol.9
, pp. 6
-
-
Pansri, P.1
Jaruseranee, N.2
Rangnoi, K.3
Kristensen, P.4
Yamabhai, M.5
-
42
-
-
0036431061
-
Functional improvement of antibody fragments using a novel phage coat protein III fusion system
-
Jensen, K.B.; Larsen, M.; Pedersen, J.S.; Christensen, P.A.; Alvarez-Vallina, L.; Goletz, S.; Clark, B.F.C.; Kristensen, P. Functional improvement of antibody fragments using a novel phage coat protein III fusion system. Biochem. Biophys. Res. Commun. 2002, 298, 566-573
-
(2002)
Biochem. Biophys. Res. Commun
, vol.298
, pp. 566-573
-
-
Jensen, K.B.1
Larsen, M.2
Pedersen, J.S.3
Christensen, P.A.4
Alvarez-Vallina, L.5
Goletz, S.6
Clark, B.F.C.7
Kristensen, P.8
-
43
-
-
84884991510
-
Isolation of human monoclonal antibodies from peripheral blood B cells
-
Huang, J.; Doria-Rose, N.A.; Longo, N.S.; Laub, L.; Lin, C.-L.; Turk, E.; Kang, B.H.; Migueles, S.A.; Bailer, R.T.; Mascola, J.R., et al. Isolation of human monoclonal antibodies from peripheral blood B cells. Nat. Protoc. 2013, 8, 1907-1915
-
(2013)
Nat. Protoc
, vol.8
, pp. 1907-1915
-
-
Huang, J.1
Doria-Rose, N.A.2
Longo, N.S.3
Laub, L.4
Lin, C.-L.5
Turk, E.6
Kang, B.H.7
Migueles, S.A.8
Bailer, R.T.9
Mascola, J.R.10
-
44
-
-
84879371196
-
Creation of recombinant antigen-binding molecules derived from hybridomas secreting specific antibodies
-
Fields, C.; O'Connell, D.; Xiao, S.; Lee, G.U.; Billiald, P.; Muzard, J. Creation of recombinant antigen-binding molecules derived from hybridomas secreting specific antibodies. Nat. Protoc. 2013, 8, 1125-1148
-
(2013)
Nat. Protoc
, vol.8
, pp. 1125-1148
-
-
Fields, C.1
O'Connell, D.2
Xiao, S.3
Lee, G.U.4
Billiald, P.5
Muzard, J.6
-
45
-
-
84883702935
-
Expression of recombinant antibodies
-
Frenzel, A.; Hust, M.; Schirrmann, T. Expression of recombinant antibodies. Front. Immunol. 2013, 4, 217
-
(2013)
Front. Immunol
, vol.4
, pp. 217
-
-
Frenzel, A.1
Hust, M.2
Schirrmann, T.3
-
46
-
-
27144432842
-
Engineered antibody fragments and the rise of single domains
-
Holliger, P.; Hudson, P.J. Engineered antibody fragments and the rise of single domains. Nat. Biotechnol. 2005, 23, 1126-1136
-
(2005)
Nat. Biotechnol
, vol.23
, pp. 1126-1136
-
-
Holliger, P.1
Hudson, P.J.2
-
47
-
-
0004198722
-
Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli
-
Huston, J.S.; Levinson, D.; Mudgett-Hunter, M.; Tai, M.S.; Novotný, J.; Margolies, M.N.; Ridge, R.J.; Bruccoleri, R.E.; Haber, E.; Crea, R. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 1988, 85, 5879-5883
-
(1988)
Proc. Natl. Acad. Sci. USA
, vol.85
, pp. 5879-5883
-
-
Huston, J.S.1
Levinson, D.2
Mudgett-Hunter, M.3
Tai, M.S.4
Novotný, J.5
Margolies, M.N.6
Ridge, R.J.7
Bruccoleri, R.E.8
Haber, E.9
Crea, R.10
-
48
-
-
0027197493
-
Diabodies: Small bivalent and bispecific antibody fragments
-
Holliger, P.; Prospero, T.; Winter, G. "Diabodies": Small bivalent and bispecific antibody fragments. Proc. Natl. Acad. Sci. USA 1993, 90, 6444-6448
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 6444-6448
-
-
Holliger, P.1
Prospero, T.2
Winter, G.3
-
49
-
-
84884945180
-
Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency
-
Turki, I.; Hammami, A.; Kharmachi, H.; Mousli, M. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency. Mol. Immunol. 2014, 57, 66-73
-
(2014)
Mol. Immunol
, vol.57
, pp. 66-73
-
-
Turki, I.1
Hammami, A.2
Kharmachi, H.3
Mousli, M.4
-
50
-
-
79958053952
-
A. Biotechnological applications of recombinant single-domain antibody fragments
-
De Marco, A. Biotechnological applications of recombinant single-domain antibody fragments. Microb. Cell Factories 2011, 10, 44
-
(2011)
Microb. Cell Factories
, vol.10
, pp. 44
-
-
De, M.1
-
51
-
-
0024461313
-
Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli
-
Ward, E.S.; Güssow, D.; Griffiths, A.D.; Jones, P.T.; Winter, G. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 1989, 341, 544-546
-
(1989)
Nature
, vol.341
, pp. 544-546
-
-
Ward, E.S.1
Güssow, D.2
Griffiths, A.D.3
Jones, P.T.4
Winter, G.5
-
52
-
-
84878935042
-
Nanobodies: Natural single-domain antibodies
-
Muyldermans, S. Nanobodies: Natural single-domain antibodies. Annu. Rev. Biochem. 2013, 82, 775-797
-
(2013)
Annu. Rev. Biochem
, vol.82
, pp. 775-797
-
-
Muyldermans, S.1
-
53
-
-
84934438262
-
Overview and discovery of IgNARs and generation of VNARs
-
Clifton, NJ, USA
-
Nuttall, S.D. Overview and discovery of IgNARs and generation of VNARs. Methods Mol. Biol. (Clifton, NJ, USA) 2012, 911, 27-36
-
(2012)
Methods Mol. Biol
, vol.911
, pp. 27-36
-
-
Nuttall, S.D.1
-
54
-
-
84857373689
-
Production of human antibody fragments binding to melittin and phospholipase A2 in Africanised bee venom: Minimising venom toxicity
-
Funayama, J.C.; Pucca, M.B.; Roncolato, E.C.; Bertolini, T.B.; Campos, L.B.; Barbosa, J.E. Production of human antibody fragments binding to melittin and phospholipase A2 in Africanised bee venom: Minimising venom toxicity. Basic Clin. Pharmacol. Toxicol. 2012, 110, 290-297
-
(2012)
Basic Clin. Pharmacol. Toxicol
, vol.110
, pp. 290-297
-
-
Funayama, J.C.1
Pucca, M.B.2
Roncolato, E.C.3
Bertolini, T.B.4
Campos, L.B.5
Barbosa, J.E.6
-
55
-
-
84881036564
-
New approaches & technologies of venomics to meet the challenge of human envenoming by snakebites in India
-
Warrell, D.A.; Gutiérrez, J.M.; Calvete, J.J.; Williams, D. New approaches & technologies of venomics to meet the challenge of human envenoming by snakebites in India. Indian J. Med. Res. 2013, 138, 38-59
-
(2013)
Indian J. Med. Res
, vol.138
, pp. 38-59
-
-
Warrell, D.A.1
Gutiérrez, J.M.2
Calvete, J.J.3
Williams, D.4
-
56
-
-
80051666142
-
Research strategies to improve snakebite treatment: Challenges and progress
-
Harrison, R.A.; Cook, D.A.; Renjifo, C.; Casewell, N.R.; Currier, R.B.; Wagstaff, S.C. Research strategies to improve snakebite treatment: Challenges and progress. J. Proteomics 2011, 74, 1768-1780
-
(2011)
J. Proteomics
, vol.74
, pp. 1768-1780
-
-
Harrison, R.A.1
Cook, D.A.2
Renjifo, C.3
Casewell, N.R.4
Currier, R.B.5
Wagstaff, S.C.6
-
57
-
-
67049126873
-
Venoms, venomics, antivenomics
-
Calvete, J.J.; Sanz, L.; Angulo, Y.; Lomonte, B.; Gutiérrez, J.M. Venoms, venomics, antivenomics. FEBS Lett. 2009, 583, 1736-1743
-
(2009)
FEBS Lett
, vol.583
, pp. 1736-1743
-
-
Calvete, J.J.1
Sanz, L.2
Angulo, Y.3
Lomonte, B.4
Gutiérrez, J.M.5
-
58
-
-
1642534543
-
Snake venom metalloproteinases: Structure/function relationships studies using monoclonal antibodies
-
Tanjoni, I.; Butera, D.; Bento, L.; Della-Casa, M.S.; Marques-Porto, R.; Takehara, H.A.; Gutiérrez, J.M.; Fernandes, I.; Moura-da-Silva, A.M. Snake venom metalloproteinases: Structure/function relationships studies using monoclonal antibodies. Toxicon Off. J. Int. Soc. Toxinol. 2003, 42, 801-808
-
(2003)
Toxicon Off. J. Int. Soc. Toxinol
, vol.42
, pp. 801-808
-
-
Tanjoni, I.1
Butera, D.2
Bento, L.3
Della-Casa, M.S.4
Marques-Porto, R.5
Takehara, H.A.6
Gutiérrez, J.M.7
Fernandes, I.8
Moura-da-Silva, A.M.9
-
59
-
-
0026522064
-
Neutralization of myotoxic phospholipases A2 from the venom of the snake Bothrops asper by monoclonal antibodies
-
Lomonte, B.; Gutiérrez, J.M.; Ramírez, M.; Díaz, C. Neutralization of myotoxic phospholipases A2 from the venom of the snake Bothrops asper by monoclonal antibodies. Toxicon Off. J. Int. Soc. Toxinol. 1992, 30, 239-245
-
(1992)
Toxicon Off. J. Int. Soc. Toxinol
, vol.30
, pp. 239-245
-
-
Lomonte, B.1
Gutiérrez, J.M.2
Ramírez, M.3
Díaz, C.4
-
60
-
-
0019940814
-
Neurotoxin-specific immunoglobulins accelerate dissociation of the neurotoxin-acetylcholine receptor complex
-
Boulain, J.C.; Ménez, A. Neurotoxin-specific immunoglobulins accelerate dissociation of the neurotoxin-acetylcholine receptor complex. Science 1982, 217, 732-733
-
(1982)
Science
, vol.217
, pp. 732-733
-
-
Boulain, J.C.1
Ménez, A.2
-
61
-
-
84901792873
-
Immunological profile of antivenoms: Preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays
-
Gutiérrez, J.M.; Lomonte, B.; Sanz, L.; Calvete, J.J.; Pla, D. Immunological profile of antivenoms: Preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays. J. Proteomics 2014, 105, 340-350
-
(2014)
J. Proteomics
, vol.105
, pp. 340-350
-
-
Gutiérrez, J.M.1
Lomonte, B.2
Sanz, L.3
Calvete, J.J.4
Pla, D.5
-
62
-
-
33644512108
-
Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera
-
Harrison, R.A.; Hasson, S.S.; Harmsen, M.; Laing, G.D.; Conrath, K.; Theakston, R.D.G. Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera. Toxicon Off. J. Int. Soc. Toxinol. 2006, 47, 364-368
-
(2006)
Toxicon Off. J. Int. Soc. Toxinol
, vol.47
, pp. 364-368
-
-
Harrison, R.A.1
Hasson, S.S.2
Harmsen, M.3
Laing, G.D.4
Conrath, K.5
Theakston, R.D.G.6
-
63
-
-
77955014031
-
Analysis of camelid IgG for antivenom development: Immunoreactivity and preclinical neutralisation of venom-induced pathology by IgG subclasses, and the effect of heat treatment
-
Cook, D.A.N.; Samarasekara, C.L.; Wagstaff, S.C.; Kinne, J.; Wernery, U.; Harrison, R.A. Analysis of camelid IgG for antivenom development: Immunoreactivity and preclinical neutralisation of venom-induced pathology by IgG subclasses, and the effect of heat treatment. Toxicon Off. J. Int. Soc. Toxinol. 2010, 56, 596-603
-
(2010)
Toxicon Off. J. Int. Soc. Toxinol
, vol.56
, pp. 596-603
-
-
Cook, D.A.N.1
Samarasekara, C.L.2
Wagstaff, S.C.3
Kinne, J.4
Wernery, U.5
Harrison, R.A.6
-
64
-
-
68349108044
-
Expression of human recombinant antibody fragments capable of partially inhibiting the phospholypase activity of Crotalus durissus terrificus venom
-
Oliveira, J.G.; Soares, S.G.; Soares, A.M.; Giglio, J.R.; Teixeira, J.E.; Barbosa, J.E. Expression of human recombinant antibody fragments capable of partially inhibiting the phospholypase activity of Crotalus durissus terrificus venom. Basic Clin. Pharmacol. Toxicol. 2009, 105, 84-91
-
(2009)
Basic Clin. Pharmacol. Toxicol
, vol.105
, pp. 84-91
-
-
Oliveira, J.G.1
Soares, S.G.2
Soares, A.M.3
Giglio, J.R.4
Teixeira, J.E.5
Barbosa, J.E.6
-
65
-
-
60149088262
-
Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin
-
Kulkeaw, K.; Sakolvaree, Y.; Srimanote, P.; Tongtawe, P.; Maneewatch, S.; Sookrung, N.; Tungtrongchitr, A.; Tapchaisri, P.; Kurazono, H.; Chaicumpa, W. Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin. J. Proteomics 2009, 72, 270-282
-
(2009)
J. Proteomics
, vol.72
, pp. 270-282
-
-
Kulkeaw, K.1
Sakolvaree, Y.2
Srimanote, P.3
Tongtawe, P.4
Maneewatch, S.5
Sookrung, N.6
Tungtrongchitr, A.7
Tapchaisri, P.8
Kurazono, H.9
Chaicumpa, W.10
-
66
-
-
84863841722
-
Recognition of Vipera ammodytes meridionalis neurotoxin vipoxin and its components using phage-displayed scFv and polyclonal antivenom sera
-
Stoyanova, V.; Aleksandrov, R.; Lukarska, M.; Duhalov, D.; Atanasov, V.; Petrova, S. Recognition of Vipera ammodytes meridionalis neurotoxin vipoxin and its components using phage-displayed scFv and polyclonal antivenom sera. Toxicon Off. J. Int. Soc. Toxinol. 2012, 60, 802-809
-
(2012)
Toxicon Off. J. Int. Soc. Toxinol
, vol.60
, pp. 802-809
-
-
Stoyanova, V.1
Aleksandrov, R.2
Lukarska, M.3
Duhalov, D.4
Atanasov, V.5
Petrova, S.6
-
67
-
-
84877717092
-
Human antibody fragments specific for Bothrops jararacussu venom reduce the toxicity of other Bothrops sp. venoms
-
Roncolato, E.C.; Pucca, M.B.; Funayama, J.C.; Bertolini, T.B.; Campos, L.B.; Barbosa, J.E. Human antibody fragments specific for Bothrops jararacussu venom reduce the toxicity of other Bothrops sp. venoms. J. Immunotoxicol. 2013, 10, 160-168
-
(2013)
J. Immunotoxicol
, vol.10
, pp. 160-168
-
-
Roncolato, E.C.1
Pucca, M.B.2
Funayama, J.C.3
Bertolini, T.B.4
Campos, L.B.5
Barbosa, J.E.6
-
68
-
-
84864332747
-
Humanized-single domain antibodies (VH/VHH) that bound specifically to Naja kaouthia phospholipase A2 and neutralized the enzymatic activity
-
Chavanayarn, C.; Thanongsaksrikul, J.; Thueng-In, K.; Bangphoomi, K.; Sookrung, N.; Chaicumpa, W. Humanized-single domain antibodies (VH/VHH) that bound specifically to Naja kaouthia phospholipase A2 and neutralized the enzymatic activity. Toxins 2012, 4, 554-567
-
(2012)
Toxins
, vol.4
, pp. 554-567
-
-
Chavanayarn, C.1
Thanongsaksrikul, J.2
Thueng-In, K.3
Bangphoomi, K.4
Sookrung, N.5
Chaicumpa, W.6
-
69
-
-
1942436845
-
Quantitative variability in the biodistribution and in toxinokinetic studies of the three main alpha toxins from the Androctonus australis hector scorpion venom
-
Devaux, C.; Jouirou, B.; Naceur Krifi, M.; Clot-Faybesse, O.; El Ayeb, M.; Rochat, H. Quantitative variability in the biodistribution and in toxinokinetic studies of the three main alpha toxins from the Androctonus australis hector scorpion venom. Toxicon Off. J. Int. Soc. Toxinol. 2004, 43, 661-669
-
(2004)
Toxicon Off. J. Int. Soc. Toxinol
, vol.43
, pp. 661-669
-
-
Devaux, C.1
Jouirou, B.2
Naceur, K.M.3
Clot-Faybesse, O.4
El Ayeb, M.5
Rochat, H.6
-
70
-
-
79960699425
-
Isolation and characterization of a human antibody fragment specific for Ts1 toxin from Tityus serrulatus scorpion
-
Amaro, I.; Riaño-Umbarila, L.; Becerril, B.; Possani, L.D. Isolation and characterization of a human antibody fragment specific for Ts1 toxin from Tityus serrulatus scorpion. Immunol. Lett. 2011, 139, 73-79
-
(2011)
Immunol. Lett
, vol.139
, pp. 73-79
-
-
Amaro, I.1
Riaño-Umbarila, L.2
Becerril, B.3
Possani, L.D.4
-
71
-
-
84861076951
-
Serrumab: A human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venom
-
Pucca, M.B.; Zoccal, K.F.; Roncolato, E.C.; Bertolini, T.B.; Campos, L.B.; Cologna, C.T.; Faccioli, L.H.; Arantes, E.C.; Barbosa, J.E. Serrumab: A human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venom. J. Immunotoxicol. 2012, 9, 173-183
-
(2012)
J. Immunotoxicol
, vol.9
, pp. 173-183
-
-
Pucca, M.B.1
Zoccal, K.F.2
Roncolato, E.C.3
Bertolini, T.B.4
Campos, L.B.5
Cologna, C.T.6
Faccioli, L.H.7
Arantes, E.C.8
Barbosa, J.E.9
-
72
-
-
84897861139
-
Serrumab: A novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities
-
Pucca, M.B.; Cerni, F.A.; Peigneur, S.; Arantes, E.C.; Tytgat, J.; Barbosa, J.E. Serrumab: A novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities. J. Immunotoxicol. 2014, 11, 133-140
-
(2014)
J. Immunotoxicol
, vol.11
, pp. 133-140
-
-
Pucca, M.B.1
Cerni, F.A.2
Peigneur, S.3
Arantes, E.C.4
Tytgat, J.5
Barbosa, J.E.6
-
73
-
-
60249092882
-
Antidotes against venomous animals: State of the art and prospectives
-
Espino-Solis, G.P.; Riaño-Umbarila, L.; Becerril, B.; Possani, L.D. Antidotes against venomous animals: State of the art and prospectives. J. Proteomics 2009, 72, 183-199
-
(2009)
J. Proteomics
, vol.72
, pp. 183-199
-
-
Espino-Solis, G.P.1
Riaño-Umbarila, L.2
Becerril, B.3
Possani, L.D.4
-
74
-
-
18944365788
-
A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom
-
Riaño-Umbarila, L.; Juárez-González, V.R.; Olamendi-Portugal, T.; Ortíz-León, M; Possani, L.D.; Becerril, B. A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom. FEBS J. 2005, 272, 2591-2601
-
(2005)
FEBS J
, vol.272
, pp. 2591-2601
-
-
Riaño-Umbarila, L.1
Juárez-González, V.R.2
Olamendi-Portugal, T.3
Ortíz-León, M.4
Possani, L.D.5
Becerril, B.6
-
75
-
-
79953225531
-
Exploiting cross-reactivity to neutralize two different scorpion venoms with one single chain antibody fragment
-
Riaño-Umbarila, L.; Contreras-Ferrat, G.; Olamendi-Portugal, T.; Morelos-Juárez, C.; Corzo, G.; Possani, L.D.; Becerril, B. Exploiting cross-reactivity to neutralize two different scorpion venoms with one single chain antibody fragment. J. Biol. Chem. 2011, 286, 6143-6151
-
(2011)
J. Biol. Chem
, vol.286
, pp. 6143-6151
-
-
Riaño-Umbarila, L.1
Contreras-Ferrat, G.2
Olamendi-Portugal, T.3
Morelos-Juárez, C.4
Corzo, G.5
Possani, L.D.6
Becerril, B.7
-
76
-
-
0036838270
-
Functional aspects of co-variant surface charges in an antibody fragment
-
Hugo, N.; Lafont, V.; Beukes, M.; Altschuh, D. Functional aspects of co-variant surface charges in an antibody fragment. Protein Sci. Publ. Protein Soc. 2002, 11, 2697-2705
-
(2002)
Protein Sci. Publ. Protein Soc
, vol.11
, pp. 2697-2705
-
-
Hugo, N.1
Lafont, V.2
Beukes, M.3
Altschuh, D.4
-
77
-
-
84867072214
-
A single mutation in framework 2 of the heavy variable domain improves the properties of a diabody and a related single-chain antibody
-
Rodríguez-Rodríguez, E.R.; Ledezma-Candanoza, L.M.; Contreras-Ferrat, L.G.; Olamendi-Portugal, T.; Possani, L.D.; Becerril, B.; Riaño-Umbarila, L. A single mutation in framework 2 of the heavy variable domain improves the properties of a diabody and a related single-chain antibody. J. Mol. Biol. 2012, 423, 337-350
-
(2012)
J. Mol. Biol
, vol.423
, pp. 337-350
-
-
Rodríguez-Rodríguez, E.R.1
Ledezma-Candanoza, L.M.2
Contreras-Ferrat, L.G.3
Olamendi-Portugal, T.4
Possani, L.D.5
Becerril, B.6
Riaño-Umbarila, L.7
-
78
-
-
0025362523
-
In vivo tumor targeting of a recombinant single-chain antigen-binding protein
-
Colcher, D.; Bird, R.; Roselli, M.; Hardman, K.D.; Johnson, S.; Pope, S.; Dodd, S.W.; Pantoliano, M.W.; Milenic, D.E.; Schlom, J. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J. Natl. Cancer Inst. 1990, 82, 1191-1197
-
(1990)
J. Natl. Cancer Inst
, vol.82
, pp. 1191-1197
-
-
Colcher, D.1
Bird, R.2
Roselli, M.3
Hardman, K.D.4
Johnson, S.5
Pope, S.6
Dodd, S.W.7
Pantoliano, M.W.8
Milenic, D.E.9
Schlom, J.10
-
79
-
-
84859101968
-
Evaluation of three different formats of a neutralizing single chain human antibody against toxin Cn2: Neutralization capacity versus thermodynamic stability
-
Quintero-Hernández, V.; del Pozo-Yauner, L.; Pedraza-Escalona, M.; Juárez-González, V.R.; Alcántara-Recillas, I.; Possani, L.D.; Becerril, B. Evaluation of three different formats of a neutralizing single chain human antibody against toxin Cn2: Neutralization capacity versus thermodynamic stability. Immunol. Lett. 2012, 143, 152-160
-
(2012)
Immunol. Lett
, vol.143
, pp. 152-160
-
-
Quintero-Hernández, V.1
del Pozo-Yauner, L.2
Pedraza-Escalona, M.3
Juárez-González, V.R.4
Alcántara-Recillas, I.5
Possani, L.D.6
Becerril, B.7
-
80
-
-
0032910690
-
A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector
-
Mousli, M.; Devaux, C.; Rochat, H.; Goyffon, M.; Billiald, P. A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector. FEBS Lett. 1999, 442, 183-188
-
(1999)
FEBS Lett
, vol.442
, pp. 183-188
-
-
Mousli, M.1
Devaux, C.2
Rochat, H.3
Goyffon, M.4
Billiald, P.5
-
81
-
-
0034834559
-
Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector
-
Devaux, C.; Moreau, E.; Goyffon, M.; Rochat, H.; Billiald, P. Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector. Eur. J. Biochem. FEBS 2001, 268, 694-702
-
(2001)
Eur. J. Biochem. FEBS
, vol.268
, pp. 694-702
-
-
Devaux, C.1
Moreau, E.2
Goyffon, M.3
Rochat, H.4
Billiald, P.5
-
82
-
-
0344080623
-
Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin
-
Aubrey, N.; Devaux, C.; Sizaret, P.Y.; Rochat, H.; Goyffon, M.; Billiald, P. Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin. Cell. Mol. Life Sci. 2003, 60, 617-628
-
(2003)
Cell. Mol. Life Sci
, vol.60
, pp. 617-628
-
-
Aubrey, N.1
Devaux, C.2
Sizaret, P.Y.3
Rochat, H.4
Goyffon, M.5
Billiald, P.6
-
83
-
-
1642389249
-
Engineering of a recombinant Fab from a neutralizing IgG directed against scorpion neurotoxin AahI, and functional evaluation versus other antibody fragments
-
Aubrey, N.; Muzard, J.; Christophe Peter, J.; Rochat, H.; Goyffon, M.; Devaux, C.; Billiald, P. Engineering of a recombinant Fab from a neutralizing IgG directed against scorpion neurotoxin AahI, and functional evaluation versus other antibody fragments. Toxicon Off. J. Int. Soc. Toxinol. 2004, 43, 233-241
-
(2004)
Toxicon Off. J. Int. Soc. Toxinol
, vol.43
, pp. 233-241
-
-
Aubrey, N.1
Muzard, J.2
Christophe, P.J.3
Rochat, H.4
Goyffon, M.5
Devaux, C.6
Billiald, P.7
-
84
-
-
77956631367
-
A bispecific nanobody to provide full protection against lethal scorpion envenoming
-
Hmila, I.; Saerens, D.; Ben Abderrazek, R.; Vincke, C.; Abidi, N.; Benlasfar, Z.; Govaert, J.; el Ayeb, M.; Bouhaouala-Zahar, B.; Muyldermans, S. A bispecific nanobody to provide full protection against lethal scorpion envenoming. FASEB J. 2010, 24, 3479-3489
-
(2010)
FASEB J
, vol.24
, pp. 3479-3489
-
-
Hmila, I.1
Saerens, D.2
Ben Abderrazek, R.3
Vincke, C.4
Abidi, N.5
Benlasfar, Z.6
Govaert, J.7
el Ayeb, M.8
Bouhaouala-Zahar, B.9
Muyldermans, S.10
-
85
-
-
84859962399
-
Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom
-
Di Tommaso, A.; Juste, M.O.; Martin-Eauclaire, M.-F.; Dimier-Poisson, I.; Billiald, P.; Aubrey, N. Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom. J. Biol. Chem. 2012, 287, 14149-14156
-
(2012)
J. Biol. Chem
, vol.287
, pp. 14149-14156
-
-
Di Tommaso, A.1
Juste, M.O.2
Martin-Eauclaire, M.-F.3
Dimier-Poisson, I.4
Billiald, P.5
Aubrey, N.6
-
86
-
-
0035715877
-
Single domain camel antibodies: Current status
-
Muyldermans, S. Single domain camel antibodies: Current status. J. Biotechnol. 2001, 74, 277-302
-
(2001)
J. Biotechnol
, vol.74
, pp. 277-302
-
-
Muyldermans, S.1
-
87
-
-
1642493838
-
Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins
-
Meddeb-Mouelhi, F.; Bouhaouala-Zahar, B.; Benlasfar, Z.; Hammadi, M.; Mejri, T.; Moslah, M.; Karoui, H.; Khorchani, T.; el Ayeb, M. Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins. Toxicon Off. J. Int. Soc. Toxinol. 2003, 42, 785-791
-
(2003)
Toxicon Off. J. Int. Soc. Toxinol
, vol.42
, pp. 785-791
-
-
Meddeb-Mouelhi, F.1
Bouhaouala-Zahar, B.2
Benlasfar, Z.3
Hammadi, M.4
Mejri, T.5
Moslah, M.6
Karoui, H.7
Khorchani, T.8
el Ayeb, M.9
-
88
-
-
0034812589
-
Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae
-
Conrath, K.E.; Lauwereys, M.; Galleni, M.; Matagne, A.; Frère, J.M.; Kinne, J.; Wyns, L.; Muyldermans, S. Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob. Agents Chemother. 2001, 45, 2807-2812
-
(2001)
Antimicrob. Agents Chemother
, vol.45
, pp. 2807-2812
-
-
Conrath, K.E.1
Lauwereys, M.2
Galleni, M.3
Matagne, A.4
Frère, J.M.5
Kinne, J.6
Wyns, L.7
Muyldermans, S.8
-
89
-
-
48049096810
-
VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI
-
Hmila, I.; Abdallah, R.B.A.-B.; Saerens, D.; Benlasfar, Z.; Conrath, K.; Ayeb, M.E.; Muyldermans, S.; Bouhaouala-Zahar, B. VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI. Mol. Immunol. 2008, 45, 3847-3856
-
(2008)
Mol. Immunol
, vol.45
, pp. 3847-3856
-
-
Hmila, I.1
Abdallah, R.B.A.-B.2
Saerens, D.3
Benlasfar, Z.4
Conrath, K.5
Ayeb, M.E.6
Muyldermans, S.7
Bouhaouala-Zahar, B.8
-
90
-
-
70450178687
-
Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom
-
Abderrazek, R.B.; Hmila, I.; Vincke, C.; Benlasfar, Z.; Pellis, M.; Dabbek, H.; Saerens, D.; el Ayeb, M.; Muyldermans, S.; Bouhaouala-Zahar, B. Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom. Biochem. J. 2009, 424, 263-272
-
(2009)
Biochem. J
, vol.424
, pp. 263-272
-
-
Abderrazek, R.B.1
Hmila, I.2
Vincke, C.3
Benlasfar, Z.4
Pellis, M.5
Dabbek, H.6
Saerens, D.7
el Ayeb, M.8
Muyldermans, S.9
Bouhaouala-Zahar, B.10
-
91
-
-
80052329487
-
Development of Cys38 knock-out and humanized version of NbAahII10 nanobody with improved neutralization of AahII scorpion toxin
-
Ben Abderrazek, R.; Vincke, C.; Hmila, I.; Saerens, D.; Abidi, N.; el Ayeb, M.; Muyldermans, S.; Bouhaouala-Zahar, B. Development of Cys38 knock-out and humanized version of NbAahII10 nanobody with improved neutralization of AahII scorpion toxin. Protein Eng. Des. Sel. PEDS 2011, 24, 727-735
-
(2011)
Protein Eng. Des. Sel. PEDS
, vol.24
, pp. 727-735
-
-
Ben Abderrazek, R.1
Vincke, C.2
Hmila, I.3
Saerens, D.4
Abidi, N.5
el Ayeb, M.6
Muyldermans, S.7
Bouhaouala-Zahar, B.8
-
92
-
-
84866870590
-
Pre-clinical studies of toxin-specific nanobodies: Evidence of in vivo efficacy to prevent fatal disturbances provoked by scorpion envenoming
-
Hmila, I.; Cosyns, B.; Tounsi, H.; Roosens, B.; Caveliers, V.; Abderrazek, R.B.; Boubaker, S.; Muyldermans, S.; el Ayeb, M.; Bouhaouala-Zahar, B., et al. Pre-clinical studies of toxin-specific nanobodies: Evidence of in vivo efficacy to prevent fatal disturbances provoked by scorpion envenoming. Toxicol. Appl. Pharmacol. 2012, 264, 222-231
-
(2012)
Toxicol. Appl. Pharmacol
, vol.264
, pp. 222-231
-
-
Hmila, I.1
Cosyns, B.2
Tounsi, H.3
Roosens, B.4
Caveliers, V.5
Abderrazek, R.B.6
Boubaker, S.7
Muyldermans, S.8
el Ayeb, M.9
Bouhaouala-Zahar, B.10
-
93
-
-
79951907939
-
Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin
-
Garcia-Rodriguez, C.; Geren, I.N.; Lou, J.; Conrad, F.; Forsyth, C.; Wen, W.; Chakraborti, S.; Zao, H.; Manzanarez, G.; Smith, T.J., et al. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng. Des. Sel. PEDS 2011, 24, 321-331
-
(2011)
Protein Eng. Des. Sel. PEDS
, vol.24
, pp. 321-331
-
-
Garcia-Rodriguez, C.1
Geren, I.N.2
Lou, J.3
Conrad, F.4
Forsyth, C.5
Wen, W.6
Chakraborti, S.7
Zao, H.8
Manzanarez, G.9
Smith, T.J.10
-
94
-
-
80052843636
-
Preclinical pharmacokinetics and safety of Sym004: A synergistic antibody mixture directed against epidermal growth factor receptor
-
Skartved, N.J.O.; Jacobsen, H.J.; Pedersen, M.W.; Jensen, P.F.; Sen, J.W.; Jørgensen, T.K.; Hey, A.; Kragh, M. Preclinical pharmacokinetics and safety of Sym004: A synergistic antibody mixture directed against epidermal growth factor receptor. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2011, 17, 5962-5972
-
(2011)
Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res
, vol.17
, pp. 5962-5972
-
-
Skartved, N.J.O.1
Jacobsen, H.J.2
Pedersen, M.W.3
Jensen, P.F.4
Sen, J.W.5
Jørgensen, T.K.6
Hey, A.7
Kragh, M.8
-
95
-
-
13844296953
-
Directed evolution, phage display and combination of evolved mutants: A strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2
-
Juárez-González, V.R.; Riaño-Umbarila, L.; Quintero-Hernández, V.; Olamendi-Portugal, T.; Ortiz-León, M.; Ortíz, E.; Possani, L.D.; Becerril, B. Directed evolution, phage display and combination of evolved mutants: A strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2. J. Mol. Biol. 2005, 346, 1287-1297
-
(2005)
J. Mol. Biol
, vol.346
, pp. 1287-1297
-
-
Juárez-González, V.R.1
Riaño-Umbarila, L.2
Quintero-Hernández, V.3
Olamendi-Portugal, T.4
Ortiz-León, M.5
Ortíz, E.6
Possani, L.D.7
Becerril, B.8
-
96
-
-
11144355014
-
Final results of the ReoPro readministration registry
-
Dery, J.-P.; Braden, G.A.; Lincoff, A.M.; Kereiakes, D.J.; Browne, K.; Little, T.; George, B.S.; Sane, D.C.; Cines, D.B.; Effron, M.B., et al. Final results of the ReoPro readministration registry. Am. J. Cardiol. 2004, 93, 979-984
-
(2004)
Am. J. Cardiol
, vol.93
, pp. 979-984
-
-
Dery, J.-P.1
Braden, G.A.2
Lincoff, A.M.3
Kereiakes, D.J.4
Browne, K.5
Little, T.6
George, B.S.7
Sane, D.C.8
Cines, D.B.9
Effron, M.B.10
-
97
-
-
77950517325
-
The safety and side effects of monoclonal antibodies
-
Hansel, T.T.; Kropshofer, H.; Singer, T.; Mitchell, J.A.; George, A.J.T. The safety and side effects of monoclonal antibodies. Nat. Rev. Drug Discov. 2010, 9, 325-338
-
(2010)
Nat. Rev. Drug Discov
, vol.9
, pp. 325-338
-
-
Hansel, T.T.1
Kropshofer, H.2
Singer, T.3
Mitchell, J.A.4
George, A.J.T.5
-
98
-
-
34248170673
-
Analyzing the "degree of humanness" of antibody sequences
-
Abhinandan, K.R.; Martin, A.C.R. Analyzing the "degree of humanness" of antibody sequences. J. Mol. Biol. 2007, 369, 852-862
-
(2007)
J. Mol. Biol
, vol.369
, pp. 852-862
-
-
Abhinandan, K.R.1
Martin, A.C.R.2
-
99
-
-
0028052724
-
Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains
-
Parker, K.C.; Bednarek, M.A.; Coligan, J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. (Baltimore, MD, USA) 1950 1994, 152, 163-175
-
(1950)
J. Immunol (Baltimore, MD, USA)
, vol.152
, pp. 163-175
-
-
Parker, K.C.1
Bednarek, M.A.2
Coligan, J.E.3
-
100
-
-
77049107081
-
Antivenom efficacy or effectiveness: The Australian experience
-
Isbister, G.K. Antivenom efficacy or effectiveness: The Australian experience. Toxicology 2010, 268, 148-154
-
(2010)
Toxicology
, vol.268
, pp. 148-154
-
-
Isbister, G.K.1
-
101
-
-
2442460970
-
Epidemiological data, clinical admission gradation and biological quantification by ELISA of scorpion envenomations in Algeria: Effect of immunotherapy
-
Hammoudi-Triki, D.; Ferquel, E.; Robbe-Vincent, A.; Bon, C.; Choumet, V.; Laraba-Djebari, F. Epidemiological data, clinical admission gradation and biological quantification by ELISA of scorpion envenomations in Algeria: Effect of immunotherapy. Trans. R. Soc. Trop. Med. Hyg. 2004, 98, 240-250.
-
(2004)
Trans. R. Soc. Trop. Med. Hyg
, vol.98
, pp. 240-250
-
-
Hammoudi-Triki, D.1
Ferquel, E.2
Robbe-Vincent, A.3
Bon, C.4
Choumet, V.5
Laraba-Djebari, F.6
|